Mirae Corporation (KRX:025560)
South Korea · Delayed Price · Currency is KRW 13,120
-530 (-3.88%)
Feb 5, 2026, 3:30 PM KST
Mirae Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 43,932 | 27,042 | 21,739 | 56,172 | 48,338 | 41,560 |
Other Revenue | - | - | - | - | - | 0 |
| 43,932 | 27,042 | 21,739 | 56,172 | 48,338 | 41,560 | |
Revenue Growth (YoY) | 120.68% | 24.39% | -61.30% | 16.21% | 16.31% | 50.08% |
Cost of Revenue | 23,518 | 4,521 | 29,102 | 34,687 | 31,577 | 32,955 |
Gross Profit | 20,414 | 22,521 | -7,362 | 21,485 | 16,762 | 8,605 |
Selling, General & Admin | 8,330 | 8,404 | 8,480 | 10,844 | 7,286 | 6,219 |
Research & Development | 550.86 | 1,051 | 1,118 | 975.99 | 1,089 | 319.52 |
Amortization of Goodwill & Intangibles | 25.05 | 29.67 | 24.42 | 46.14 | 21.65 | 81.17 |
Other Operating Expenses | 195.05 | 110.95 | 105.91 | 95.58 | 180.15 | 97.18 |
Operating Expenses | 9,161 | 12,070 | 10,943 | 13,166 | 11,472 | 7,437 |
Operating Income | 11,253 | 10,451 | -18,305 | 8,319 | 5,290 | 1,169 |
Interest Expense | -1,208 | -1,616 | -1,697 | -1,865 | -1,306 | -716.99 |
Interest & Investment Income | 587.2 | 1,208 | 264.03 | 415.69 | 346.03 | 523.21 |
Earnings From Equity Investments | - | - | 145.77 | -118.83 | 6.38 | -10 |
Currency Exchange Gain (Loss) | 630.61 | 1,055 | 376.58 | 103.26 | 1,486 | -260.27 |
Other Non Operating Income (Expenses) | 2,300 | -796.02 | -6,937 | -218.58 | -1,171 | -1,203 |
EBT Excluding Unusual Items | 13,563 | 10,302 | -26,153 | 6,635 | 4,651 | -498.03 |
Gain (Loss) on Sale of Investments | -2,533 | -2,506 | -1,647 | -425.4 | 1,143 | -4,186 |
Gain (Loss) on Sale of Assets | -43.08 | 0.24 | -107.16 | 16.84 | 1,920 | 37.35 |
Asset Writedown | -843.42 | -843.22 | - | -1,479 | - | -2,076 |
Other Unusual Items | -13.13 | - | -393.6 | - | - | - |
Pretax Income | 10,130 | 6,953 | -28,301 | 4,748 | 7,715 | -6,722 |
Income Tax Expense | -142.77 | -153.82 | 662.3 | 36.01 | 224.64 | - |
Earnings From Continuing Operations | 10,273 | 7,107 | -28,963 | 4,712 | 7,490 | -6,722 |
Earnings From Discontinued Operations | - | -502.87 | -2,539 | 3,312 | - | - |
Net Income to Company | 10,273 | 6,604 | -31,502 | 8,023 | 7,490 | -6,722 |
Net Income | 10,273 | 6,604 | -31,502 | 8,023 | 7,490 | -6,722 |
Net Income to Common | 10,273 | 6,604 | -31,502 | 8,023 | 7,490 | -6,722 |
Net Income Growth | - | - | - | 7.12% | - | - |
Shares Outstanding (Basic) | 4 | 2 | 2 | 2 | 2 | 1 |
Shares Outstanding (Diluted) | 5 | 3 | 2 | 2 | 2 | 1 |
Shares Change (YoY) | 155.73% | 64.19% | -13.38% | 33.88% | 22.54% | 31.40% |
EPS (Basic) | 2764.41 | 3225.04 | -17520.05 | 4828.80 | 4914.33 | -5312.64 |
EPS (Diluted) | 2302.77 | 2792.53 | -17524.05 | 4300.10 | 4875.14 | -5312.64 |
EPS Growth | - | - | - | -11.79% | - | - |
Free Cash Flow | -28,180 | -35,936 | 6,498 | -547.01 | 2,257 | -1,255 |
Free Cash Flow Per Share | -5767.78 | -12172.41 | 3613.73 | -263.51 | 1455.49 | -992.04 |
Gross Margin | 46.47% | 83.28% | -33.87% | 38.25% | 34.68% | 20.71% |
Operating Margin | 25.61% | 38.65% | -84.20% | 14.81% | 10.94% | 2.81% |
Profit Margin | 23.38% | 24.42% | -144.91% | 14.28% | 15.50% | -16.18% |
Free Cash Flow Margin | -64.14% | -132.89% | 29.89% | -0.97% | 4.67% | -3.02% |
EBITDA | 12,304 | 11,443 | -17,637 | 9,125 | 5,886 | 2,266 |
EBITDA Margin | 28.01% | 42.32% | -81.13% | 16.25% | 12.18% | 5.45% |
D&A For EBITDA | 1,051 | 991.93 | 667.93 | 805.96 | 596.18 | 1,097 |
EBIT | 11,253 | 10,451 | -18,305 | 8,319 | 5,290 | 1,169 |
EBIT Margin | 25.61% | 38.65% | -84.20% | 14.81% | 10.94% | 2.81% |
Effective Tax Rate | - | - | - | 0.76% | 2.91% | - |
Advertising Expenses | - | 127.56 | 118.34 | 118.45 | 26.16 | 128.08 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.